Saudi Central Bank lifted its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 90.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,396 shares of the financial services provider’s stock after purchasing an additional 12,086 shares during the quarter. Saudi Central Bank’s holdings in CME Group were worth $5,608,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. BlackRock Inc. bought a new stake in CME Group during the second quarter valued at approximately $6,749,965,000. Norges Bank bought a new position in shares of CME Group in the 4th quarter worth $1,523,241,000. Bank of New York Mellon Corp bought a new position in shares of CME Group in the 2nd quarter worth $867,313,000. Alphabet Inc. purchased a new stake in shares of CME Group during the 2nd quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of CME Group during the 2nd quarter valued at $629,771,000. 87.75% of the stock is currently owned by institutional investors.
CME Group Stock Performance
Shares of CME opened at $281.29 on Monday. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm has a market cap of $101.15 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 3.32 and a beta of 0.24. The firm has a 50 day moving average price of $258.76 and a 200-day moving average price of $278.20. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $320.00 target price on shares of CME Group in a research report on Thursday, July 2nd. Barclays lowered their price target on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Piper Sandler dropped their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Bank of America upped their price objective on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a report on Thursday, July 23rd. Finally, Morgan Stanley increased their price objective on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $289.75.
View Our Latest Stock Analysis on CME
Insider Transactions at CME Group
In related news, Director William Shepard acquired 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. 0.30% of the stock is currently owned by insiders.
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Recommended Stories
- Five stocks we like better than CME Group
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
